Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-mediated FAK Phosphorylation

Cui Zhai,Meng Cao,Nana Zhang,Jian Wang,Qianqian zhang,Yanting Zhu,Qingting Wang,Shaojun Li
DOI: https://doi.org/10.21203/rs.3.rs-1274598/v2
2022-01-01
Abstract:Abstract Background: Activation of autophagy induces the proliferation of pulmonary artery smooth muscle cells (PASMCs) and vascular remodeling in rats, and therefore improves the development of pulmonary arterial hypertension (PAH). However, the possible mechanisms underlying autophagy in PAH have not been completely understood. The aims of this study are to address these issues. Method: Rat models of PAH were induced by intraperitoneally injection of monocrotaline (MCT). The right ventricle systolic pressure (RVSP), right ventricular hypertrophy index (RVHI), percentage of medial wall thickness (%MT), α-smooth muscle actin (α-SMA) staining and Ki67 staining were performed to evaluate the development of PAH. The protein levels of forkhead box M1 (FOXM1), focal adhesion kinase (FAK), phospho-FAK, and LC3B were determined by immunoblotting and immunohistochemistry. Results: FOXM1 protein level and the activation of FAK and autophagy were significantly increased in MCT-induced PAH rats. Pharmacological inhibition of FOXM1 and FAK suppressed MCT-induced autophagy activation, and reduced RVSP, RVHI and %MT, and ameliorated the proliferation of pulmonary arterial smooth muscle cells in MCT-induced PAH rats. Conclusion: FOXM1 induces the development of PAH by activation of FAK and consequent stimulating autophagy in MCT-treated rats.
What problem does this paper attempt to address?